Stemcells (STEM) Misses Q1 EPS by 19c

Stemcells (NASDAQ: STEM) reported Q1 EPS of ($0.45), $0.19 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $373 thousand versus the consensus estimate of $330 thousand.

For earnings history and earnings-related data on Stemcells (STEM) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
• zSpace, Inc. (ZSPC) Reports Q2 results